Glucotrack (GCTK) Amortization of Deferred Charges (2010 - 2025)
Glucotrack (GCTK) recorded quarterly Amortization of Deferred Charges of $177000.0 in Q4 2025, up 470.97% on a QoQ basis from $31000.0 in Q3 2025, and down 40.6% year-over-year from $298000.0 in Q4 2024.
Glucotrack (GCTK) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends
Glucotrack has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $177000.0 for Q4 2025.
- Quarterly Amortization of Deferred Charges fell 40.6% year-over-year to $177000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (changed N/A YoY) and the FY2025 annual result came in at $182000.0, down 71.02% from the prior year.
- Amortization of Deferred Charges rose to $177000.0 in Q4 2025, from $31000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $298000.0 in Q4 2024 and troughed at $2000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 177,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Dec 31, 2010 | 269,475.00 |
| Dec 31, 2010 | 269,475.00 |